Table 4.
Neonatal Outcome | Maternal Indication n=395 | Fetal/Obstetric Indication n=133 | AOR (95% CI) | P value |
---|---|---|---|---|
Neonatal Composite Outcome | 85 (21.5%) | 52 (39.1%) | 1.9 (1.14–3.21)* | <0.01 |
Neonatal Death | 17 (4.3%) | 13 (9.8%) | 1.7 (0.74–4.10) † | 0.02 |
Cord pH<7 or base excess<−12.5 | 11 (2.8%) | 17 (12.8%) | 4.2 (1.89–9.55)‡ | <0.01 |
Grade III-IV Intraventricular Hemorrhage (%) | 15 (3.8%) | 1 (0.8%) | 0.1(0.02–1.13)‡ | 0.08 |
Culture-Proven Sepsis | 29/371 (7.8%) | 19 /123 (15.5%) | 1.7 (0.84–3.46) ‡ | 0.01 |
Necrotizing Enterocolitis | 27 (6.9%) | 14 (10.6%) | 1.3 (0.61–2.66) † | 0.17 |
5-Minute Apgar ≤3 | 26 (6.6%) | 17 (12.8%) | 1.4 (0.68–2.89) ‡ | 0.02 |
CPR in Delivery Room | 1 (0.3%) | 1 (0.8%) | - | 0.41 |
Adjusted for use of steroids, gestational age at delivery and BMI
Adjusted for use of steroids and gestational age at delivery
Adjusted for use of steroids, gestational age at delivery and race
Primary Neonatal Composite Outcome factors include the following: (i) death, (ii) pH<7, (iii) 5 minute Apgar ≤ 3, (iv) CPR in the labor and delivery room, (v) sepsis, (vi) IV.